Drug Type Small molecule drug |
Synonyms ACA |
Target |
Action inhibitors |
Mechanism ERK2 inhibitors(Extracellular-signal-regulated kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Intervertebral Disc Degeneration | Preclinical | China | 24 Oct 2025 | |
| Neoplasms | Preclinical | South Korea | 26 Sep 2025 |





